Related Topics
Startup targets HIV drug resistance in developing countries
June 15, 2016— A low-cost test for HIV drug resistance developed at Harvard T.H. Chan School of Public Health could help clinicians in developing countries more quickly determine the best antiretroviral (ARV) drug for their patients. The researchers behind…
Botswana study shows 96% rate of viral suppression for patients on HIV drugs
Ahead of many Western nations, African country close to meeting new UNAIDS testing and treatment targets For immediate release: Wednesday, March 23, 2016 Boston, MA – Botswana appears to have achieved very high rates of HIV diagnosis, treatment, and…
Presidential candidates say little about health challenges
The current presidential candidates “have precious little to say” about some of the most compelling challenges relating to the nation’s health—such as the fact that Americans are living shorter lives and experiencing poorer health than people in many…
Q&A: A New Test For Drug-Resistant HIV Breaks All the Scientific Rules
[Winter 2016] A former postdoctoral fellow with the Harvard T.H. Chan School of Public Health AIDS Initiative, virologist Iain MacLeod in 2014 cofounded Aldatu Biosciences, which provides sensitive and cost-effective diagnostics to detect drug resistance in antiretroviral treatments…
Experts focus on translational science at global health event
December 16, 2015 – More than 40 national and international health leaders gathered December 10-11, 2015, at Harvard T.H. Chan School of Public Health for a Stakeholder’s Advisory Board (SAB) conference supporting Donna Spiegelman’s National Institutes of Health…
In pursuit of an elusive foe
The bacteria that cause tuberculosis are experts at survival, allowing the disease to persist even when faced with the immune system and drugs. Harvard T.H. Chan School of Public Health’s Sarah Fortune is on a mission to figure out…
Progress, challenges in tackling pediatric HIV/AIDS
December 7, 2015 -- Since the first World AIDS Day in 1988, the first day in December has been a day to remember those who have died in the epidemic and to acknowledge progress made in treatment and…
Monitoring the safety of ARV therapy during pregnancy
December 1, 2015 — Paige Williams, senior lecturer on biostatistics at Harvard T.H. Chan School of Public Health, studies the health and development of children whose HIV-infected mothers took antiretroviral (ARV) drugs during pregnancy. In a study published…
HIV treatment benefiting women more than men in South Africa
A new long-term study in South Africa has found that increased access to effective HIV treatment is boosting life expectancy—but among women more than men. The study, published November 24, 2015 in PLOS Medicine, looked at nearly 100,000…
How racism impacts health
November 3, 2015 — Public health professionals must not be afraid to use the word “racism” when they see health inequities linked to issues like poverty, segregation, and lack of access to care, Mary Travis Bassett, commissioner of…
